Delivery Order SPE2DB20D1100-SPE2DB25FZ89F
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,424.90, is a delivery order for the supply of RESTASIS 0.05% eye emulsion. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award (SPE2DB20D2104/SPE2DB25FMGYE) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,960.64, is for the delivery of RESTASIS 0.05% eye emulsion 60s. This is a firm fixed-price delivery order contract with a completion date of January 31, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,494.15, is a delivery order for RESTASIS 0.05% eye emulsion products. The contract has a firm-fixed price pricing type and an ultimate completion date of March 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award, valued at $2,745.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of RESTASIS 0.05% Eye Emulsion 30s, a prescription eye medication. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This federal contract award, valued at $8,018.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of RESTASIS 0.05% eye emulsion in 60-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The award, with a ceiling value of $2,794.50, is a firm fixed-price delivery order that will be fulfilled by December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,471.20 Firm Fixed Price Delivery Order contract is for the supply of RESTASIS 0.05% Eye Emulsion 30s, a prescription ophthalmic medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,060.28, is for the delivery of RESTASIS 0.05% eye emulsion to support military healthcare programs. The contract is a firm fixed-price delivery order with a completion date of November 1, 2023. It is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.07 firm fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a prescription eye medication. The contract has an ultimate completion date of May 1, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,922.21, is for the delivery of RESTASIS 0.05% eye emulsion, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 19, 2025. This award is not associated with a set-aside requirement. Amerisourcebergen holds a significant...